Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
497.00    -2.40 (-0.48%)
Bid:
496.40
Ask:
497.20
Spread: 0.80 (0.161%)
Market Cap: £1.34b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Contract Win

29 Sep 2016 10:53

RNS Number : 2040L
Chemring Group PLC
29 September 2016
 

FOR IMMEDIATE RELEASE 29 SEPTEMBER 2016

 

ELECTRONIC WARFARE CONTRACT WIN

 

Chemring Group PLC ("Chemring" or "the Group"), is pleased to announce that its subsidiary Chemring Australia has been awarded an A$18 million contract by the Australian Department of Defence to supply Chemring's Resolve 3 electronic warfare manpack system.

 

Resolve 3 is the latest iteration of the highly successful, combat-proven, Resolve electronic surveillance system, designed and produced by UK-based Chemring Technology Solutions. Up to 50 man-portable systems will be delivered during the first 18 months of the contract, with the systems being assembled at Chemring Australia's facility at Mulgrave, Victoria.

 

Michael Flowers, Group Chief Executive of Chemring, commented: "Resolve 3 represents the latest in man-portable electronic surveillance capability and I am delighted that Chemring Australia has won this contract. This is the largest award that the Group has received for the Resolve system, growing Resolve's user-base to nine countries and builds on Chemring's position as a market leader in electronic warfare."

-ENDS-

 

For further information:

 

Michael Flowers Group Chief Executive, Chemring Group PLC 01794 833901

Rupert Pittman Group Director of Corporate Affairs, 01794 833901

Chemring Group PLC

 

James White MHP Communications 0203 128 8100

 

Cautionary statement

 

This announcement contains unaudited information based on management accounts and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

 

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

About Chemring Group

· Chemring is a global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

· Employing approximately 2,700 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is organised under three strategic product segments: Countermeasures, Sensors & Electronics, and Energetic Systems

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.co.uk

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALLMLTMBITMLF
Date   Source Headline
1st May 201910:07 amRNSTotal Voting Rights
10th Apr 20192:12 pmRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSDisposal of Chemring Military Products, Inc.
2nd Apr 20195:44 pmRNSHolding(s) in Company
2nd Apr 201910:39 amRNSDirector/PDMR Shareholding
1st Apr 201910:29 amRNSTotal Voting Rights
25th Mar 20195:09 pmRNSDoc re. Ordinary & Special Resolutions
25th Mar 20193:40 pmRNSHolding(s) in Company
25th Mar 20193:36 pmRNSHolding(s) in Company
25th Mar 20198:51 amRNSDirector/PDMR Shareholding
25th Mar 20198:47 amRNSDirector/PDMR Shareholding
25th Mar 20198:47 amRNSDirector/PDMR Shareholding
21st Mar 20192:43 pmRNSResult of AGM
21st Mar 20197:00 amRNSAGM Trading Update
20th Mar 20194:03 pmRNSHolding(s) in Company
19th Mar 20197:11 amRNSDirector Declaration
1st Mar 201911:40 amRNSTotal Voting Rights
21st Feb 201910:27 amRNSDirector/PDMR Shareholding
20th Feb 20191:30 pmRNSNotice of Annual General Meeting
1st Feb 20191:55 pmRNSTotal Voting Rights
18th Jan 201910:17 amRNSDirector/PDMR Shareholding
17th Jan 20197:00 amRNSRESULTS FOR THE YEAR ENDED 31 OCTOBER 2018
7th Jan 20198:51 amRNSDirector Declaration
2nd Jan 20199:49 amRNSTotal Voting Rights
19th Dec 201811:40 amRNSBlock listing Interim Review
3rd Dec 20189:58 amRNSTotal Voting Rights
19th Nov 201811:31 amRNSDirectorate Change
19th Nov 201811:17 amRNSDirectorate Change
15th Nov 20187:00 amRNSPost year-end statement
16th Oct 20182:56 pmRNSHolding(s) in Company
2nd Oct 201810:21 amRNSTotal Voting Rights
5th Sep 20187:00 amRNSNGCD NOTIFICATION
4th Sep 20187:00 amRNSTrading Update
3rd Sep 20182:38 pmRNSTotal Voting Rights
16th Aug 20187:00 amRNSHMDS Contract award
15th Aug 201812:20 pmRNSHolding(s) in Company
13th Aug 20187:00 amRNSINCIDENT AT CHEMRING COUNTERMEASURES
8th Aug 20187:12 amRNSDirectorate Change
6th Aug 20182:16 pmRNSHolding(s) in Company
1st Aug 20189:32 amRNSTotal Voting Rights
30th Jul 20181:24 pmRNSDirector/PDMR Shareholding
2nd Jul 201810:44 amRNSTotal Voting Rights
2nd Jul 20187:00 amRNSCONTRACT AWARDS
26th Jun 20183:54 pmRNSDirector/PDMR Shareholding
22nd Jun 20182:40 pmRNSBlock listing Interim Review
22nd Jun 20182:39 pmRNSBlock listing Interim Review
21st Jun 20187:00 amRNSINTERIM RESULTS
8th Jun 20181:37 pmRNSAdditional Listing
4th Jun 20187:00 amRNSTotal Voting Rights
24th May 20187:00 amRNSCONTRACT AWARDS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.